Molecular 'rabble-rouser' fuels pancreatic cancer growth
A type of molecular 'rabble-rouser' that triggers pancreatic cancer to become aggressive and spread around the body has been identified by scientists.
May 10, 2018
0
102
A type of molecular 'rabble-rouser' that triggers pancreatic cancer to become aggressive and spread around the body has been identified by scientists.
May 10, 2018
0
102
The addition of two particular gene snippets to a skin cell's usual genetic material is enough to turn that cell into a fully functional neuron, report researchers from the Stanford University School of Medicine. The finding, ...
Jul 13, 2011
0
0
Patients suffering from an aggressive brain cancer will benefit from the results of a University of Illinois study that could advance the development of targeted gene therapies and improve prognosis.
Aug 22, 2011
0
0
Facioscapulohumeral muscular dystrophy (FSHD) is caused by aberrant expression of the DUX4 gene in skeletal muscles. Researchers at Nationwide Children's Hospital have recently demonstrated that an endogenous human microRNA, ...
Dec 14, 2021
0
100
A team of Texas A&M and Texas A&M AgriLife Research scientists now have a deeper understanding of a large switch/sucrose non-fermentable (SWI/SNF) protein complex that plays a pivotal role in plant and human gene expression ...
May 17, 2018
0
47
A team of University of Florida researchers has developed a promising new CRISPR-powered method for non-invasive blood tests that could help clinicians diagnose cancer at earlier stages.
May 31, 2023
0
43
In cancer therapeutics research, microRNAs—tiny strings of nucleotides that get churned out inside cells—have been a source of both excitement and disappointment. While preclinical studies have found that microRNAs play ...
Jan 25, 2019
0
39
Blocking two tiny molecules of RNA a chemical cousin of DNA appears to suppress the abnormal growth of blood vessels that occurs in degenerative eye disorders, UT Southwestern Medical Center researchers have ...
Jun 7, 2011
0
0
Relapse of disease following conventional treatments remains one of the central problems in cancer management, yet few therapeutic agents targeting drug resistance and tolerance exist. New research conducted at the Cancer ...
Apr 8, 2019
0
91
A new study from the Netherlands Institute for Neuroscience and the VIB-KU Leuven Center for Brain and Disease Research shows that a very small molecule called microRNA-132 can have a significant impact on different brain ...
Jun 15, 2023
0
59